本文へ移動
cccskills
無料GitHub で公開

pdm-metformin-insulin-avoid

Recommends against routine addition of metformin to insulin for pregnant individuals with type 2 diabetes already on insulin. Triggered when considering adding metformin to an insulin regimen in pregnancy for patients with type 2 diabetes.

インストール方法を見る

含まれるファイル(1)

  • SKILL.md2.3 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Avoid routine addition of metformin to insulin in pregnancy with type 2 diabetes

STEP 1 — Gather Information

Confirm pregnancy diagnosis, type 2 diabetes mellitus, current insulin therapy, and evaluate glycemic control and maternal weight; assess for any contraindications to metformin (e.g., renal impairment, GI intolerance).

STEP 2 — Rule In / Rule Out

Is the patient pregnant with preexisting type 2 diabetes and currently on insulin? If yes, proceed to Step 3; if no, this guideline does not apply.

STEP 3 — Classify or Stratify

Assess whether there is a specific, evidence-based indication for metformin beyond routine glycemic control (e.g., severe insulin resistance requiring dose reduction) versus routine consideration; if no specific indication, classify as routine addition scenario.

STEP 4 — Decide

Do not routinely add metformin to insulin; continue insulin monotherapy and optimize insulin dosing based on glucose monitoring; consider metformin only in exceptional cases after shared decision-making discussing potential risks (e.g., increased SGA, adverse childhood outcomes).

Clinical Guardrails / Mimics / Pitfalls

Avoid adding metformin solely to reduce insulin dose or gestational weight gain without weighing potential fetal harms; do not overlook placental transfer of metformin and associated risks of fetal growth restriction and long-term metabolic effects; do not use metformin as a substitute for insulin in type 2 diabetes pregnancy.

Concrete Clinical Example

A 32-year-old pregnant woman with type 2 diabetes on basal-bolus insulin reports persistent hyperglycemia despite dose titration; clinician considers adding metformin but, after discussing lack of benefit for LGA reduction versus potential SGA increase, decides against routine metformin addition and intensifies insulin regimen instead.

Source: Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline, Endocrine Society and European Society of Endocrinology, 2025, DOI: 10.1210/clinem/dgaf288

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する